April 30th 2024
FDA-approves mpox vaccine, FDA grants EUA for at-home multiplex papid test, FDA grants PDUFA for GSK 5-in-1 meningococcal vaccine, and more this month from the FDA.
Penn Nursing and New York Blood Center Aim to Develop HIV Prevention Program for Women
December 2nd 2016The National Institute of Mental Health has granted researchers at the University of Pennsylvania School of Nursing and New York Blood Center $769,578 to go towards efforts to create an HIV awareness program for women.
Read More
NIH Launches First New HIV Vaccine Efficacy Study in 7 Years in South Africa
November 29th 2016The first HIV vaccine efficacy study in seven years is currently being conducted in South Africa, with researchers testing if a new vaccine regimen called HVTN 702 can provide adequate protection against HIV.
Read More
Buyers Clubs Big Business for HIV and HCV Drugs
November 18th 2016Buyers clubs are still going strong in the United States and around the world as the offer a low-cost alternative for individuals with HIV and hepatitis c virus (HCV) who often find themselves struggling to pay for the expensive medications they need to treat their illness.
Read More
Rapid Syphilis Screening Useful in Community-based Clinics and Organizations
November 3rd 2016Rapid syphilis screening tests can be useful in community-based facilities, according to the results of five studies presented in a mini-plenary on September 22 at the Centers for Disease Control and Prevention 2016 STD Prevention Conference in Atlanta, Georgia.
Read More
Ibalizumab Beneficial for Previously Treated Patients with Multi-Drug-Resistant HIV-1 Infection
November 2nd 2016The monoclonal antibody, ibalizumab, has proven to be both safe and effective in treating patients who are infected with multi-drug-resistant HIV-1 and have been previously treated.
Read More
Living Longer with HIV Brings New Challenges
October 31st 2016At the annual meeting of the Infectious Diseases Society of America in New Orleans, Louisiana, Judith Currier, MD, from the University of California, Los Angeles, discussed the many challenges that HIV-positive individuals face as they live longer lives.
Read More
ASPIRE HIV Prevention Study Reveals Several Key Findings
October 26th 2016During the 2016 HIV Research and Prevention (HIVR4P) meeting in Chicago, researchers conducting trials to assess the safety and efficacy of the dapivirine vaginal ring announced several key findings and insights of the ASPIRE study, known as MTN-020.
Read More